News | Stroke | September 28, 2017

Majority of High-Risk Stroke Patients Not Being Screened for Common Risk Factors

New research identifies significant gaps between recommended guidelines and clinical practice for stroke prevention across 20 countries

Majority of High-Risk Stroke Patients Not Being Screened for Common Risk Factors

September 28, 2017 — New research revealed that on average, more than 75 percent of people aged 65 and older worldwide are not being screened for atrial fibrillation (AF) and other common stroke risk factors during routine primary care examinations, even though this population is at high risk for stroke.

The “Preventing Stroke: Uneven Progress Report,” released by The Economist Intelligence Unit (EIU), a division of The Economist and sponsored by The Bristol-Myers Squibb-Pfizer Alliance, conducted an analysis of 20 countries and found that efforts to screen people for stroke risk factors including AF and hypertension varied widely, even in countries with established healthcare and developed economies.

“Stroke is the second leading cause of death globally, accounting for 6.2 million deaths,1 but is nearly 80 percent preventable,”2 said Becca Lipman, editor of the EIU’s thought leadership division and of this report. “Our hope is that this research will elevate the awareness and urgency surrounding screening for stroke risk factors including AF and hypertension and offer suggestions on what can be done on a country-by-country level to further improve prevention. There are critical and urgent opportunities to improve screening, so that fewer people suffer the devastating consequences of stroke.”

The report considered policy efforts to assess and reduce risks of stroke across different aspects including awareness, screening practices and policies. Key findings include:

  • There is a disconnect between established best practices and everyday clinical practice. For example, there are gaps in the training of healthcare professionals to properly identify and treat stroke risks;
  • Screening for AF and hypertension remains low and is not regularly performed in clinical practice; and
  • Future policies should focus on strategies to improve awareness of stroke risk factors, implement systematic and/or opportunistic screenings, and include both individual and population-based health-intervention approaches.

“People with AF are at least three times more likely to have a stroke than those without this condition,”3,4,5 said Rory O’Connor, M.D., chief medical officer, Pfizer Internal Medicine. “Even modest improvements in diagnosis and treatment of stroke risk factors including AF – supported by collaborations across healthcare providers, advocates, policymakers and the private sector – could potentially prevent many strokes and related deaths.”6

The EIU developed a scorecard to assess each country’s performance across four different categories and conducted in-depth interviews with experts on cardiovascular health and stroke, which were included in the final report.

For more information: www.eiuperspectives.economist.com

References

1. Top 10 Causes of Death. (webpage) World Health Organization. Accessed on August 10, 2017. http://www.who.int/mediacentre/factsheets/fs310/en/.
2. Myth vs. Fact: Stroke Facts (webpage). National Stroke Association. Accessed on August 10, 2017. http://www.stroke.org/understand-stroke/what-stroke/stroke-facts
3. January, C. T. (2014). ACC/AHA/HRS Guideline for the Management of Patients with Atrial Fibrillation. Circulation, 130, E212-E212. doi:10.1161/CIR.0000000000000041/-/DC1.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991;22: 983–8.
5. Spodato LA, Cipriano LE, Saposnik G. (2015). Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2015; 14: 377–87.
6. Stroke Facts. The U.S. Centers for Disease Control and Prevention (CDC). (webpage) Accessed on August 10, 2017. https://www.cdc.gov/stroke/facts.htm
7. Ben Freedman, Tatjana S. Potpara, and Gregory Y H Lip, "Stroke prevention in atrial fibrillation," The Lancet 388, no. 10046 (2016): , doi:10.1016/s0140-6736(16)31257-0.

Related Content

Videos | TCT| November 15, 2017
DAIC Editor Dave Fornell shows some of the innovations displayed on the expo floor at the 2017 Transcatheter Cardiova
GE Healthcare and Medis Collaborate to Expand Availability of Quantitative Flow Ratio Software
News | FFR Technologies| November 10, 2017
GE Healthcare and Dutch-based cardiovascular imaging software provider Medis announced at the 2017 Transcatheter...
Videos | Structural Heart Occluders| November 08, 2017
John Rhodes, M.D., co-director of the adult congenital heart program, Medical University of South Carolina, is the pr
Statins Attributed With 10-Year Cholesterol Drop for Malaysian Heart Attack Patients
News | Antiplatelet and Anticoagulation Therapies| November 03, 2017
November 3, 2017 — A ten-year decline in the blood cholesterol of heart attack patients in Malaysia suggests...
VitalConnect Raises $38 Million in Series C Equity Financing
News | Wearable Sensors| November 03, 2017
November 3, 2017 — VitalConnect Inc.
Analytics 4 Life Presents Clinical Data on Machine-Learned Cardiac Imaging Technology at TCT 2017
News | Cardiac Diagnostics| November 01, 2017
Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary Artery Disease...
Abbott SJM St. Jude Confirm RX implantable cardiac monitor (ICM).

The Abbott Confirm RX implantable cardiac monitor (ICM) is smaller than a computer thumb-drive and in implanted in a simple in-office procedure just under the skin.

Technology | Implantable Cardiac Monitor (ICM)| October 23, 2017
October 23, 2017 – The U.S.
American Heart Association, Verily and AstraZeneca Launch One Brave Idea Science Innovation Center
News | Cardiac Diagnostics| October 20, 2017
The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea Science Innovation...
Cardiovascular Risk Significantly Higher in Women With Fatty Liver Disease
News | Womens Healthcare| October 20, 2017
Nonalcoholic fatty liver disease (NAFLD) is associated with significantly higher risk of subsequent cardiovascular...
Analytics 4 Life Raises $25 Million for AI-Backed Cardiac Imaging Technology
News | Advanced Visualization| October 20, 2017
October 20, 2017 — Digital health company Analytics 4 Life announced it has completed a $25 million Series B financin
Overlay Init